Cite
HARVARD Citation
Ferenci, P. et al. (2013). Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon‐a2a/ribavirin in combination with a direct‐acting anti‐viral – authors' reply. Alimentary pharmacology & therapeutics. 38 (5), p. 558. [Online].